Efficacy and Safety of Eculizumab in Pediatric Patients Affected by Shiga Toxin-Related Hemolytic and Uremic Syndrome: A Randomized, Placebo-Controlled Trial.
幼童患者接受 Eculizumab 治療與安全性:一項針對與席加毒素相關的溶血性尿毒症候群的隨機、安慰劑對照試驗。
J Am Soc Nephrol 2023-10-18
Eculizumab in STEC-HUS: a paradigm shift in the management of pediatric patients with neurological involvement.
Eculizumab在STEC-HUS中的應用:改變兒童患者神經系統參與管理的典範。
Pediatr Nephrol 2023-11-30
New findings in preventing recurrence and improving renal function in AHUS patients after renal transplantation treated with eculizumab: a systemic review and meta-analyses.
AHUS患者接受依度膜珠單抗治療後腎移植的復發預防和腎功能改善的新發現:系統回顧和荟萃分析。
Ren Fail 2023-08-16
Outcome of atypical hemolytic uremic syndrome: role of triggers and complement abnormalities in the response to C5 inhibition.
非典型溶血性尿毒症個案結果:觸發因素及補體異常在對C5抑制反應中的角色。
J Nephrol 2024-01-27
Eculizumab for adult patients with atypical haemolytic-uraemic syndrome: full dataset analysis of Japanese post-marketing surveillance.
成人非典型溶血性尿毒症候群使用 Eculizumab:日本後市場監測的完整數據分析。
J Nephrol 2024-05-29